CATALOGO DEI PRODOTTI DELLA RICERCA

BELLINATO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.545
NA - Nord America 2.739
AS - Asia 2.364
SA - Sud America 460
AF - Africa 151
OC - Oceania 46
Totale 9.305
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.650
RU - Federazione Russa 1.783
SG - Singapore 1.082
IT - Italia 539
CN - Cina 420
BR - Brasile 378
HK - Hong Kong 280
DE - Germania 227
GB - Regno Unito 200
VN - Vietnam 162
IE - Irlanda 160
SE - Svezia 140
FI - Finlandia 120
FR - Francia 111
KR - Corea 97
NL - Olanda 65
ID - Indonesia 63
IN - India 52
TR - Turchia 50
TG - Togo 47
ES - Italia 45
BJ - Benin 41
CA - Canada 41
AU - Australia 40
JP - Giappone 37
MX - Messico 36
PL - Polonia 31
AR - Argentina 27
AT - Austria 25
ZA - Sudafrica 23
IR - Iran 17
EC - Ecuador 16
CL - Cile 13
MY - Malesia 13
SA - Arabia Saudita 13
BD - Bangladesh 12
UA - Ucraina 12
PH - Filippine 10
CH - Svizzera 9
CO - Colombia 9
DK - Danimarca 8
HR - Croazia 8
IQ - Iraq 8
BE - Belgio 7
UZ - Uzbekistan 7
DZ - Algeria 6
EG - Egitto 6
NG - Nigeria 6
PK - Pakistan 6
PT - Portogallo 6
RO - Romania 6
GR - Grecia 5
IL - Israele 5
IS - Islanda 5
NZ - Nuova Zelanda 5
UY - Uruguay 5
AZ - Azerbaigian 4
BG - Bulgaria 4
HU - Ungheria 4
KE - Kenya 4
MA - Marocco 4
PY - Paraguay 4
TN - Tunisia 4
VE - Venezuela 4
AL - Albania 3
BH - Bahrain 3
CZ - Repubblica Ceca 3
ET - Etiopia 3
GD - Grenada 3
GE - Georgia 3
GH - Ghana 3
LT - Lituania 3
NO - Norvegia 3
NP - Nepal 3
TW - Taiwan 3
AO - Angola 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
HN - Honduras 2
JM - Giamaica 2
JO - Giordania 2
RS - Serbia 2
AD - Andorra 1
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
CG - Congo 1
CI - Costa d'Avorio 1
DM - Dominica 1
EE - Estonia 1
FK - Isole Falkland (Malvinas) 1
GT - Guatemala 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
Totale 9.294
Salva come PNG Salva come JPEG
Città #
Dallas 801
Moscow 643
Singapore 491
Ashburn 314
Chandler 267
Hong Kong 267
Dublin 149
Munich 113
Beijing 90
New York 89
Los Angeles 80
Helsinki 76
The Dalles 65
Ho Chi Minh City 64
London 61
Milan 60
Verona 51
Jakarta 49
Lomé 47
Cotonou 41
Southend 39
Hanoi 37
Redondo Beach 37
Rome 35
Lawrence 34
Princeton 34
Buffalo 32
São Paulo 32
Houston 28
Naples 28
Seattle 28
Lappeenranta 27
Warsaw 26
Jacksonville 25
Sindelfingen 25
Wilmington 25
Santa Clara 24
Tokyo 24
Washington 24
Amsterdam 23
Chicago 23
Bologna 20
Nuremberg 19
Venice 19
Chennai 18
Mexico City 18
Brooklyn 17
Frankfurt am Main 17
Phoenix 17
Atlanta 16
Sydney 16
Council Bluffs 15
Tianjin 15
Madrid 14
Johannesburg 13
Kuala Lumpur 13
Orem 13
Xi'an 13
Boston 12
Enfield 12
Guangzhou 12
Rio de Janeiro 12
Turin 12
Belo Horizonte 11
Istanbul 11
Montreal 11
Shanghai 11
Toronto 11
Brasília 10
Columbus 10
Perth 10
Dongguan 9
Esslingen am Neckar 9
Florence 9
Mumbai 9
Vienna 9
Da Nang 8
Jinan 8
Mersin 8
Santiago 8
Stockholm 8
Copenhagen 7
Curitiba 7
Denver 7
Palermo 7
San Jose 7
Tashkent 7
Turku 7
Vicenza 7
Ankara 6
Ann Arbor 6
Barcelona 6
Brussels 6
Downers Grove 6
Genoa 6
Goiânia 6
Haiphong 6
Jyväskylä 6
Kent 6
Las Vegas 6
Totale 5.053
Salva come PNG Salva come JPEG
Nome #
Il ruolo della vitamina D nella dermatite atopica 298
A systematic review of treatments for pityriasis lichenoides 295
Real-World Effectiveness of Bimekizumab in Predominantly Difficult-to-Treat Patients with Psoriatic Arthritis Followed in a Combined Dermatology-Rheumatology Clinic: A 24-Week Multicenter Study 285
Dietary supplements for lipedema 279
Five-year drug survival of dupilumab in atopic dermatitis: Italian landscape AD real-world study 251
Clinical features and treatments of transient acantholytic dermatosis (Grover’s disease): a systematic review 152
Acquired perforating dermatoses show increased levels of cutaneous advanced glycation end-products 152
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 152
Polymorphisms, diet and nutrigenomics 147
BRAF V600E expression in juvenile xanthogranuloma occurring after Langerhans cell histiocytosis. 143
Impact of the COVID-19 pandemic on melanoma diagnosis 143
Clinical and immunological profile of patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid 137
A dermatologist perspective in the pharmacological treatment of patients with psoriasis and psoriatic arthritis 132
Alopecic and aseptic nodules of the scalp: A new case with a systematic review of the literature 132
Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis 132
Amicrobial Pustulosis of the Folds: Report of Three New Cases 123
Adrenergic urticaria successfully treated with omalizumab 115
Hypochondriasis and Personality Traits of Patients with Chronic Plaque Psoriasis 111
Association between short-term exposure to environmental air pollution and atopic dermatitis flare in patients treated with dupilumab 110
Coexistence of scleromyxedema and Sneddon syndrome 109
Cost per Responder Analysis of Secukinumab versus Adalimumab in the Treatment of Psoriatic Disease 108
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study 107
Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis 107
Clinical profile and co-infections of urethritis in males 106
Clinical Characteristics of Patients with Pustular Psoriasis: A Single-Center Retrospective Observational Study 105
Central Pain Sensitization in Patients with Chronic Plaque Psoriasis 104
Psychological Stress and Salivary Cortisol Levels in Patients with Plaque Psoriasis 103
Dermoscopic features of nevoid melanoma: a retrospective study 98
Time of Onset of Selected Skin Lesions Associated with COVID-19: A Systematic Review 98
Comparative dermoscopy assessment of nevus-associated versus de novo in situ melanoma 97
Price variability of TNF-α inhibitor biosimilars among European countries 97
Cost per responder of Adalimumab biosimilars MSB11022 and ABP 501 versus the originator and methotrexate in chronic plaque psoriasis 96
Pretibial Dystrophic Epidermolysis Bullosa Successfully Treated with Upadacitinib: A Case Report 96
Consensus on the place in therapy of TNF-a inhibitors in the treatment of patients with chronic plaque psoriasis 96
The transition from mild to moderate-to-severe chronic plaque psoriasis 92
Clinical‐epidemiological aspects of the Monkeypox 2022 epidemic: a multicenter study by the Italian SIDeMaST Group of Sexually Transmitted, Infectious and Tropical Diseases 89
Persistent localized hypertrichosis in a Caucasian child at sites of DTPa and chickenpox vaccination 88
Primary nodular localized cutaneous amyloidosis of the scalp associated with systemic lupus erythematosus 87
BRAF-Mutated Melanoma Cell Lines Develop Distinct Molecular Signatures After Prolonged Exposure to AZ628 or Dabrafenib: Potential Benefits of the Antiretroviral Treatments Cabotegravir or Doravirine on BRAF-Inhibitor-Resistant Cells 85
Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis 85
Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities 85
Methotrexate vs secukinumab safety in psoriasis patients with metabolic syndrome 85
Spesolimab in patients with flare of generalized pustular psoriasis: A multicentre case-series 83
IL-17A inhibitors in patients with chronic plaque psoriasis and history of malignancy: A case series with systematic literature review 82
Main nutritional deficiencies 81
Predictors of subsequent primary melanoma: a case-control study 80
The safety profile of hydroxychloroquine: major cutaneous and extracutaneous adverse events 80
Risk of developing psoriatic arthritis in patients with psoriasis initiating treatment with different classes of biologics 79
Awareness of obesity among patients with psoriasis 79
Diagnosis and Treatment of Infantile Hemangioma from the Primary Care Paediatricians to the Specialist: A Narrative Review 78
Certolizumab pegol in severe hidradenitis suppurativa in pregnancy: A case report 78
Sezary syndrome with large cell transformation and T-follicular helper phenotype 78
Dietary supplements for the management of COVID-19 symptoms 77
Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines 77
Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies 76
Cross-Switch from Etanercept Originator to Biosimilar SB4 and to GP2015 in Patients with Chronic Plaque Psoriasis 76
Preference for Telemedicine Versus In-Person Visit Among Patients with Psoriasis Receiving Biological Drugs 76
Dupilumab for recalcitrant Kimura disease 76
Managing the Patient with Psoriasis and Metabolic Comorbidities 73
Lamivudine, Doravirine, and Cabotegravir downregulate the expression of Human Endogenous Retroviruses (HERVs), inhibit cell growth, and reduce invasive capability in melanoma cell lines 72
Relapse of psoriasis in patients who asked to discontinue etanercept after achieving a stable clinical remission. 72
In vitro cell culture of amniotic fluid keratinocytes on amniotic membrane: the ideal tissue for repairing skin ulcers 71
Immune Response to Vaccination in Patients with Psoriasis Treated with Systemic Therapies 71
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian study 69
Optimization of long-range PCR protocol to prepare filaggrin exon 3 libraries for PacBio long-read sequencing 68
Latest Advances for the Treatment of Chronic Plaque Psoriasis with Biologics and Oral Small Molecules 68
Upadacitinib in refractory cutaneous pseudolymphoma: A case report 68
The Risk of COVID‐19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments 67
Enhancing Skin Cancer Prevention and Awareness in the Italian Population: Insights from the “Save Your Skin” Screening Campaign 66
Brodalumab for the treatment of moderate-to-severe plaque-type psoriasis: a real-life, retrospective 24-week experience 66
Systematic study on nail plate assessment: differences in nail plate shape, thickness, power Doppler signal and scanning approach 65
Non-Alcoholic Fatty Liver Disease Is Associated With Reduced Glomerular Filtration Rate in Patients With Chronic Plaque Psoriasis 65
Risk of lymphohematologic malignancies in patients with chronic plaque psoriasis: A systematic review with meta-analysis 64
Skin adverse reactions to Sars‐CoV‐2 vaccination: a relevant responsibility issue for dermatologists 64
The impact of biologic therapy for moderate-to-severe psoriasis on the immune responses to SARS-CoV2 infection and vaccination 63
Monkeypox virus infection: what dermatologist needs to know? 62
Validating methods for testing natural molecules on molecular pathways of interest in silico and in vitro 61
Cutaneous Adverse Reactions to SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis 61
Is risankizumab as needed administration a good option for patients with plaque psoriasis? 60
Reduction of cutaneous advanced glycation end products levels after effective psoriasis treatment 59
Generalized pustular psoriasis successfully treated with spesolimab: A case report 56
Polyphenols and Lactobacillus reuteri in oral health 54
Biosimilars for the Treatment of Moderate to Severe Chronic Plaque Psoriasis 53
Novel loss-of-function variants in filaggrin exon 3 in patients with severe atopic dermatitis 51
X-linked genodermatoses from diagnosis to tailored therapy 51
Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohort 50
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study 49
Omics sciences and precision medicine in melanoma 49
Topographic Differential Diagnosis of Chronic Plaque Psoriasis: Challenges and Tricks 49
Could Targeted Pharmacotherapies Exert a "Disease Modification Effect" in Patients with Chronic Plaque Psoriasis? 48
The Risk of COVID-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments 47
Use of biologics during the COVID-19 pandemic: lessons learned from psoriasis 46
Scurvy as Presenting Sign of Anorexia Nervosa 46
Long-term follow-up of Zoon balanitis: a retrospective cohort study 45
Prevalence of Non-Alcoholic Fatty Liver Disease in Adult Individuals with Moderate-to-Severe Atopic Dermatitis 44
Psoriasis: talking points from recent clinical trials 43
Disease Severity Is Associated with Alexithymia in Patients with Atopic Dermatitis 43
PsoBioVax: A multicentric Italian case–control study of the immunological response to anti‐SARS‐CoV‐2 vaccine among psoriatic patients under biological therapy 40
Corymbose Syphilis 40
Super Responder Profle Under Bimekizumab Treatment in Moderate‐to‐Severe Psoriasis: A Short Term Real‐Life Observation—IL PSO (Italian Landscape Psoriasis) 39
Totale 9.166
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.425
article - articoli 36.425
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.850
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202150 0 0 0 0 0 14 10 1 4 4 13 4
2021/2022224 12 27 4 12 31 12 15 16 11 12 17 55
2022/20231.126 38 72 63 144 63 203 15 53 210 157 78 30
2023/2024940 59 64 97 102 82 166 67 57 16 44 108 78
2024/20252.473 119 104 125 379 118 145 227 112 376 192 167 409
2025/20264.542 423 480 684 883 1.754 318 0 0 0 0 0 0
Totale 9.441